Electroencephalogram (EEG) neurofeedback's efficacy in reducing the symptoms of patients with alcohol dependence syndrome is well-documented in previous literature. Here, a case is being described who presented with alcohol dependence syndrome was given EEG neurofeedback training. After 10 sessions of EEG neurofeedback training program, a significant reduction was found in the cognitive deficits, anxiety, and depression of the patient. Furthermore, noticeable improvement was found in his memory and neurological functioning. He also showed a significant reduction in his alcohol intake on follow-up.
Background: The present study focuses upon the effects of cognitive remediation programme upon the working memory deficits of the patients with schizophrenic disorder. Schizophrenia is a chronic, severe and debilitating psychiatric illness. It is often described in terms of positive and negative symptoms. The working memory deficits are considered a cardinal cognitive feature of schizophrenia. Methods: Five patients admitted in Ranchi Institute of Neuro-Psychiatry and Allied Sciences (RINPAS), Ranchi, India in the age range of 20 to 40 years of male sex, meeting the ICD-10 DCR criteria of schizophrenia with minimum education of 12 years were taken for the study, following purposive sampling technique. A self developed socio-demographic and clinical data sheet was used to assess the socio-demographic correlates, the Positive and Negative Symptom Scale developed was used for assessing the psychotic symptoms, The Wisconsin Card Sorting Test and the Stroop test was used for assessing the executive functions and the Letter-Number Sequencing and Spatial Span Subtests taken from the Wechsler Memory Scale-III were used for assessing the working memory of the subjects included in the study. Then a cognitive remediation programme was given to them for a period of three months after which the tests were readministered to see the effects of the intervention programme. Results: The patients suffering from schizophrenia show improved working memory ability after the cognitive remediation programme. Conclusion: Cognitive remediation programme has a positive effect upon the executive functioning,specially working memory of the patients suffering from schizophrenic disorder.
A descriptive research study was conducted nonadherence and reasons of nonadherence to drug regimen among schizophrenic patients at psychiatric OPD, BSMC & H, Bankura, West Bengal to investigate the nonadherence and reasons of nonadherence to drug regimen among schizophrenic patients and to find out its association with selected demographic variables among schizophrenic patients at psychiatric OPD, BSMC & H, Bankura, West Bengal. Data were collected from 120 samples by simple random sampling using semi structured demographic tool, Medication adherence rating scale (MARS) and structured interview schedule. Majority of the patients (57.50%) were nonadherent to drug regimen. Within patient related reasons majority (74%) of patients having reasons of nonadherence due to medicines are costly to buy; among hospital related reasons, 63% of the patients having hospital is far away from their home, and within miscellaneous reasons 51% unable to come to hospital due to lock down. Nonadherence among schizophrenic patients were significant with gender, education, occupation, type of family, monthly per capita income, residence, addiction status, and duration of illness at 0.05 level. Study was implicated on nursing practice, education, administration and research. An experimental study can be conducted to explore the effectiveness of awareness programme to improve adherence among schizophrenic patients.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.